Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
First Solar
FSLR
|
+$24.3M |
| 2 |
Lamb Weston
LW
|
+$21.6M |
| 3 |
Ovintiv
OVV
|
+$21.3M |
| 4 |
Hubbell
HUBB
|
+$21.3M |
| 5 |
U-Haul Holding Co Series N
UHAL.B
|
+$19.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$627M |
| 2 |
Microsoft
MSFT
|
+$479M |
| 3 |
Amazon
AMZN
|
+$203M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$169M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$150M |
Sector Composition
| 1 | Technology | 25.32% |
| 2 | Healthcare | 16.62% |
| 3 | Consumer Discretionary | 10.98% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Generation Bio
GBIO
$41.4M
| $420K | ﹤0.01% |
10,680
+610
| +6% | +$24K |
|
2602
PMV Pharmaceuticals
PMVP
$84.8M
| $419K | ﹤0.01% |
48,200
| – | – |
|
|
PAMT
2603
PAMT CORP Common Stock
PAMT
$239M
| $417K | ﹤0.01% |
+16,115
| New | +$417K |
|
|
IGMS
2604
DELISTED
IGM Biosciences
IGMS
| $417K | ﹤0.01% |
24,500
+1,800
| +8% | +$30.6K |
|
2605
Hippo Holdings
HIPO
$925M
| $414K | ﹤0.01% |
30,408
+3,800
| +14% | +$51.7K |
|
|
CMAX
2606
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $413K | ﹤0.01% |
3,773
| – | – |
|
|
LBC
2607
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $411K | ﹤0.01% |
37,000
+1,500
| +4% | +$16.7K |
|
2608
MeiraGTx Holdings
MGTX
$615M
| $409K | ﹤0.01% |
62,800
| – | – |
|
2609
Kodak
KODK
$473M
| $407K | ﹤0.01% |
133,600
+3,900
| +3% | +$11.9K |
|
2610
HBT Financial
HBT
$813M
| $407K | ﹤0.01% |
+20,800
| New | +$407K |
|
2611
Evolv Technologies
EVLV
$1.44B
| $406K | ﹤0.01% |
156,700
+5,200
| +3% | +$13.5K |
|
|
BBBY
2612
DELISTED
Bed Bath & Beyond Inc
BBBY
| $404K | ﹤0.01% |
160,900
| – | – |
|
2613
Angi Inc
ANGI
$803M
| $400K | ﹤0.01% |
17,040
| – | – |
|
2614
Dream Finders Homes
DFH
$2.75B
| $396K | ﹤0.01% |
45,700
| – | – |
|
|
ENFN
2615
DELISTED
Enfusion, Inc.
ENFN
| $391K | ﹤0.01% |
40,400
+1,700
| +4% | +$16.4K |
|
2616
Advantage Solutions
ADV
$623M
| $390K | ﹤0.01% |
187,600
| – | – |
|
2617
The Honest Company
HNST
$438M
| $390K | ﹤0.01% |
129,500
| – | – |
|
|
EGIO
2618
DELISTED
Edgio, Inc. Common Stock
EGIO
| $390K | ﹤0.01% |
8,620
+427
| +5% | +$19.3K |
|
2619
Adicet Bio
ACET
$66.9M
| $389K | ﹤0.01% |
43,500
+1,200
| +3% | +$10.7K |
|
2620
Cellebrite
CLBT
$4.22B
| $388K | ﹤0.01% |
89,000
| – | – |
|
|
HUT
2621
Hut 8
HUT
$3.09B
| $384K | ﹤0.01% |
89,600
+10,360
| +13% | +$44.4K |
|
2622
Y-mAbs Therapeutics
YMAB
$390M
| $376K | ﹤0.01% |
77,100
| – | – |
|
2623
BRC Inc
BRCC
$180M
| $375K | ﹤0.01% |
61,400
| – | – |
|
2624
Precigen
PGEN
$1.23B
| $370K | ﹤0.01% |
243,700
| – | – |
|
2625
Quantum-Si Incorporated
QSI
$233M
| $369K | ﹤0.01% |
201,900
+7,400
| +4% | +$13.5K |
|